Law Firm Links Vaxart to Possible Securities Fraud Investigation
Hagens Berman encouraged investors and potential whistleblowers to contact the firm regarding its investigation into possible securities fraud involving Vaxart. The probe focuses on whether Vaxart misled investors about Operation Warp Speed’s potential funding support after a June 26, 2020 claim of selection for a non-human challenge study, while citing investors’ losses and the SEC whistleblower program.